Florida Cancer Specialists & Research Institute Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer

PRESERVE-003 Stage 1 evaluation of gotistobart published in Nature Medicine FORT MYERS, Fla., April 7, 2026 /PRNewswire/ -- Key findings from stage 1 of the PRESERVE-003 Phase 3 clinical trial conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS)...